October 18, 2023
After a series of startling kickback cases, Novartis Pharmaceuticals on Wednesday contrasted its past misdeeds with newer accusations it bribed prescribers, and Second Circuit judges seemed sympathetic as they pressured a whistleblower's lawyer to substantiate a supposed nationwide scheme.
September 14, 2022
A New York federal judge has tossed a lawsuit accusing Novartis of running a scheme to improperly get doctors to prescribe a multibillion-dollar multiple sclerosis treatment, finding the former employee who brought the suit fell short on proving there was a kickback strategy.